The star of the story is saarvienin A, a brand-new glycopeptide antibiotic produced by an unusual strain of Amycolatopsis, a genus of bacteria known for making medical heavy-hitters like vancomycin.

Researchers have discovered saarvienin A, a novel glycopeptide antibiotic from a rare earth mine bacterium. It shows potent ...

Saarvienin A's special feature became clear early on: Unlike established glycopeptides such as vancomycin, the new compound does not bind the typical bacterial target involved in cell wall synthesis.

structure and interactions of cellular molecules such as nucleic acids and proteins that carry out the biological processes essential for the cell s functions and maintenance. Chromatin ...

END-seq analysis of three different ALT-positive cell lines (G292, SAOS2 and U2OS) revealed that the majority of telomeric reads correspond to C-rich reads starting with the canonical CCAATC-5’ ...